Suppr超能文献

促甲状腺激素释放激素基因上异常的组蛋白修饰与甲状腺激素抵抗:F455S突变型甲状腺激素受体的分析

Aberrant histone modifications at the thyrotropin-releasing hormone gene in resistance to thyroid hormone: analysis of F455S mutant thyroid hormone receptor.

作者信息

Umezawa Ryohei, Yamada Masanobu, Horiguchi Kazuhiko, Ishii Sumiyasu, Hashimoto Koshi, Okada Shuichi, Satoh Teturou, Mori Masatomo

机构信息

Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan.

出版信息

Endocrinology. 2009 Jul;150(7):3425-32. doi: 10.1210/en.2008-1738. Epub 2009 Mar 19.

Abstract

We reported a novel mutation of thyroid hormone receptor (TR)-beta, F455S, in a patient with pituitary resistance to thyroid hormone (RTH), who showed impaired release of nuclear receptor corepressor and abnormal histone deacetylation. In the present study, we further analyzed the histone modifications and the dynamics of TR and RNA polymerase II on the TRH gene. The lysine residues 9 (H3K9) and 14 (K14) of the histone H3 were acetylated in the absence of thyroid hormone (TH), and addition of TH caused a temporary deacetylation of both residues. Although H3K4 was di- and trimethylated in the absence of T(3), no methylation of H3K9 or K27 was detected. Long-term incubation with T(3) decreased the level of trimethylated H3K4, the amount of TR, and the level of phosphorylated RNA polymerase II but not dimethylated H3K4. Treatment with an inhibitor for H3K4 methyltransferase, 5'-deoxy-5'-methylthioadenosine, decreased basal promoter activity but did not affect the repression by TH. Conversely, overexpression of MLL, an H3K4-specific methyltransferase, caused an increase in basal activity. In the presence of F455S, methylation of H3K4 and the dynamics of TR were intact, but both H3K9 and H3K14 were hyperacetylated, and T(3)-induced deacetylation was impaired, resulting in a high transcriptional level. These findings demonstrated that 1) negative regulation of the TRH gene by TH involves both the acetylation and methylation of specific residues of histone tails and changing the amount of TR, and 2) the major impairment to histone modifications in F455S was hyperacetylation of the specific histone tails.

摘要

我们报道了一名垂体性甲状腺激素抵抗(RTH)患者甲状腺激素受体(TR)-β的一种新型突变F455S,该患者表现出核受体共抑制因子释放受损和异常的组蛋白去乙酰化。在本研究中,我们进一步分析了促甲状腺激素释放激素(TRH)基因上的组蛋白修饰以及TR和RNA聚合酶II的动态变化。在无甲状腺激素(TH)的情况下,组蛋白H3的赖氨酸残基9(H3K9)和14(K14)被乙酰化,添加TH导致这两个残基暂时去乙酰化。尽管在无T3的情况下H3K4发生了二甲基化和三甲基化,但未检测到H3K9或K27的甲基化。长期用T3孵育会降低三甲基化H3K4的水平、TR的量以及磷酸化RNA聚合酶II的水平,但不会降低二甲基化H3K4的水平。用H3K4甲基转移酶抑制剂5'-脱氧-5'-甲硫腺苷处理会降低基础启动子活性,但不影响TH的抑制作用。相反,H3K4特异性甲基转移酶MLL的过表达会导致基础活性增加。在存在F455S的情况下,H3K4的甲基化和TR的动态变化是完整的,但H3K9和H3K14均过度乙酰化,且T3诱导的去乙酰化受损,导致转录水平升高。这些发现表明:1)TH对TRH基因的负调控涉及组蛋白尾部特定残基的乙酰化和甲基化以及TR量的变化;2)F455S中组蛋白修饰的主要损伤是特定组蛋白尾部的过度乙酰化。

相似文献

引用本文的文献

1
H3K14: A histone site closely related to diseases.H3K14:一个与疾病密切相关的组蛋白位点。
J Cancer. 2025 Jul 28;16(11):3537-3550. doi: 10.7150/jca.118273. eCollection 2025.
5
Aberrant Histone Methylation in Patients with Graves' Disease.格雷夫斯病患者的异常组蛋白甲基化
Int J Endocrinol. 2019 Jun 24;2019:1454617. doi: 10.1155/2019/1454617. eCollection 2019.

本文引用的文献

3
New insights into thyroid hormone action.甲状腺激素作用的新见解。
Best Pract Res Clin Endocrinol Metab. 2007 Jun;21(2):193-208. doi: 10.1016/j.beem.2007.04.004.
5
The role of chromatin during transcription.染色质在转录过程中的作用。
Cell. 2007 Feb 23;128(4):707-19. doi: 10.1016/j.cell.2007.01.015.
6
Chromatin modifications and their function.染色质修饰及其功能。
Cell. 2007 Feb 23;128(4):693-705. doi: 10.1016/j.cell.2007.02.005.
7
The mammalian epigenome.哺乳动物表观基因组。
Cell. 2007 Feb 23;128(4):669-81. doi: 10.1016/j.cell.2007.01.033.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验